[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Age-Related Macular Degeneration (AMD) Market Report 2016

November 2016 | 97 pages | ID: U3A195C18A0EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Age-Related Macular Degeneration (AMD)

Revenue, means the sales value of Age-Related Macular Degeneration (AMD)

This report studies sales (consumption) of Age-Related Macular Degeneration (AMD) in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
  • Acucela
  • Alimera Sciences, Inc.
  • Bayer Ag.
  • F. Hoffmann-La Roche Ltd
  • Glaxosmithkline Plc
  • Neurotech Pharmaceuticals, Inc.
  • Novartis Ag
  • Ophthotech Corporation
  • Regeneron Pharmaceutical, Inc.
  • Stemcells Inc.
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
  • Type I
  • Type II
  • Type III
Split by applications, this report focuses on sales, market share and growth rate of Age-Related Macular Degeneration (AMD) in each application, can be divided into
  • Application 1
  • Application 2
  • Application 3
United States Age-Related Macular Degeneration (AMD) Market Report 2016

1 AGE-RELATED MACULAR DEGENERATION (AMD) OVERVIEW

1.1 Product Overview and Scope of Age-Related Macular Degeneration (AMD)
1.2 Classification of Age-Related Macular Degeneration (AMD)
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Age-Related Macular Degeneration (AMD)
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Age-Related Macular Degeneration (AMD) (2011-2021)
  1.4.1 United States Age-Related Macular Degeneration (AMD) Sales and Growth Rate (2011-2021)
  1.4.2 United States Age-Related Macular Degeneration (AMD) Revenue and Growth Rate (2011-2021)

2 UNITED STATES AGE-RELATED MACULAR DEGENERATION (AMD) COMPETITION BY MANUFACTURERS

2.1 United States Age-Related Macular Degeneration (AMD) Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Age-Related Macular Degeneration (AMD) Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Age-Related Macular Degeneration (AMD) Average Price by Manufactures (2015 and 2016)
2.4 Age-Related Macular Degeneration (AMD) Market Competitive Situation and Trends
  2.4.1 Age-Related Macular Degeneration (AMD) Market Concentration Rate
  2.4.2 Age-Related Macular Degeneration (AMD) Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES AGE-RELATED MACULAR DEGENERATION (AMD) SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Age-Related Macular Degeneration (AMD) Sales and Market Share by Type (2011-2016)
3.2 United States Age-Related Macular Degeneration (AMD) Revenue and Market Share by Type (2011-2016)
3.3 United States Age-Related Macular Degeneration (AMD) Price by Type (2011-2016)
3.4 United States Age-Related Macular Degeneration (AMD) Sales Growth Rate by Type (2011-2016)

4 UNITED STATES AGE-RELATED MACULAR DEGENERATION (AMD) SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Age-Related Macular Degeneration (AMD) Sales and Market Share by Application (2011-2016)
4.2 United States Age-Related Macular Degeneration (AMD) Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES AGE-RELATED MACULAR DEGENERATION (AMD) MANUFACTURERS PROFILES/ANALYSIS

5.1 Acucela
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Age-Related Macular Degeneration (AMD) Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Acucela Age-Related Macular Degeneration (AMD) Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Alimera Sciences, Inc.
  5.2.2 Age-Related Macular Degeneration (AMD) Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Alimera Sciences, Inc. Age-Related Macular Degeneration (AMD) Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Bayer Ag.
  5.3.2 Age-Related Macular Degeneration (AMD) Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Bayer Ag. Age-Related Macular Degeneration (AMD) Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 F. Hoffmann-La Roche Ltd
  5.4.2 Age-Related Macular Degeneration (AMD) Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 F. Hoffmann-La Roche Ltd Age-Related Macular Degeneration (AMD) Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Glaxosmithkline Plc
  5.5.2 Age-Related Macular Degeneration (AMD) Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Glaxosmithkline Plc Age-Related Macular Degeneration (AMD) Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Neurotech Pharmaceuticals, Inc.
  5.6.2 Age-Related Macular Degeneration (AMD) Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Neurotech Pharmaceuticals, Inc. Age-Related Macular Degeneration (AMD) Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Novartis Ag
  5.7.2 Age-Related Macular Degeneration (AMD) Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Novartis Ag Age-Related Macular Degeneration (AMD) Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Ophthotech Corporation
  5.8.2 Age-Related Macular Degeneration (AMD) Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Ophthotech Corporation Age-Related Macular Degeneration (AMD) Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Regeneron Pharmaceutical, Inc.
  5.9.2 Age-Related Macular Degeneration (AMD) Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Regeneron Pharmaceutical, Inc. Age-Related Macular Degeneration (AMD) Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Stemcells Inc.
  5.10.2 Age-Related Macular Degeneration (AMD) Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Stemcells Inc. Age-Related Macular Degeneration (AMD) Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview

6 AGE-RELATED MACULAR DEGENERATION (AMD) MANUFACTURING COST ANALYSIS

6.1 Age-Related Macular Degeneration (AMD) Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Age-Related Macular Degeneration (AMD)

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Age-Related Macular Degeneration (AMD) Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Age-Related Macular Degeneration (AMD) Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES AGE-RELATED MACULAR DEGENERATION (AMD) MARKET FORECAST (2016-2021)

10.1 United States Age-Related Macular Degeneration (AMD) Sales, Revenue Forecast (2016-2021)
10.2 United States Age-Related Macular Degeneration (AMD) Sales Forecast by Type (2016-2021)
10.3 United States Age-Related Macular Degeneration (AMD) Sales Forecast by Application (2016-2021)
10.4 Age-Related Macular Degeneration (AMD) Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
LIST OF TABLES AND FIGURES

Figure Picture of Age-Related Macular Degeneration (AMD)
Table Classification of Age-Related Macular Degeneration (AMD)
Figure United States Sales Market Share of Age-Related Macular Degeneration (AMD) by Type in 2015
Table Application of Age-Related Macular Degeneration (AMD)
Figure United States Sales Market Share of Age-Related Macular Degeneration (AMD) by Application in 2015
Figure United States Age-Related Macular Degeneration (AMD) Sales and Growth Rate (2011-2021)
Figure United States Age-Related Macular Degeneration (AMD) Revenue and Growth Rate (2011-2021)
Table United States Age-Related Macular Degeneration (AMD) Sales of Key Manufacturers (2015 and 2016)
Table United States Age-Related Macular Degeneration (AMD) Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Age-Related Macular Degeneration (AMD) Sales Share by Manufacturers
Figure 2016 Age-Related Macular Degeneration (AMD) Sales Share by Manufacturers
Table United States Age-Related Macular Degeneration (AMD) Revenue by Manufacturers (2015 and 2016)
Table United States Age-Related Macular Degeneration (AMD) Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Age-Related Macular Degeneration (AMD) Revenue Share by Manufacturers
Table 2016 United States Age-Related Macular Degeneration (AMD) Revenue Share by Manufacturers
Table United States Market Age-Related Macular Degeneration (AMD) Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Age-Related Macular Degeneration (AMD) Average Price of Key Manufacturers in 2015
Figure Age-Related Macular Degeneration (AMD) Market Share of Top 3 Manufacturers
Figure Age-Related Macular Degeneration (AMD) Market Share of Top 5 Manufacturers
Table United States Age-Related Macular Degeneration (AMD) Sales by Type (2011-2016)
Table United States Age-Related Macular Degeneration (AMD) Sales Share by Type (2011-2016)
Figure United States Age-Related Macular Degeneration (AMD) Sales Market Share by Type in 2015
Table United States Age-Related Macular Degeneration (AMD) Revenue and Market Share by Type (2011-2016)
Table United States Age-Related Macular Degeneration (AMD) Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Age-Related Macular Degeneration (AMD) by Type (2011-2016)
Table United States Age-Related Macular Degeneration (AMD) Price by Type (2011-2016)
Figure United States Age-Related Macular Degeneration (AMD) Sales Growth Rate by Type (2011-2016)
Table United States Age-Related Macular Degeneration (AMD) Sales by Application (2011-2016)
Table United States Age-Related Macular Degeneration (AMD) Sales Market Share by Application (2011-2016)
Figure United States Age-Related Macular Degeneration (AMD) Sales Market Share by Application in 2015
Table United States Age-Related Macular Degeneration (AMD) Sales Growth Rate by Application (2011-2016)
Figure United States Age-Related Macular Degeneration (AMD) Sales Growth Rate by Application (2011-2016)
Table Acucela Basic Information List
Table Acucela Age-Related Macular Degeneration (AMD) Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Acucela Age-Related Macular Degeneration (AMD) Sales Market Share (2011-2016)
Table Alimera Sciences, Inc. Basic Information List
Table Alimera Sciences, Inc. Age-Related Macular Degeneration (AMD) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Alimera Sciences, Inc. Age-Related Macular Degeneration (AMD) Sales Market Share (2011-2016)
Table Bayer Ag. Basic Information List
Table Bayer Ag. Age-Related Macular Degeneration (AMD) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer Ag. Age-Related Macular Degeneration (AMD) Sales Market Share (2011-2016)
Table F. Hoffmann-La Roche Ltd Basic Information List
Table F. Hoffmann-La Roche Ltd Age-Related Macular Degeneration (AMD) Sales, Revenue, Price and Gross Margin (2011-2016)
Table F. Hoffmann-La Roche Ltd Age-Related Macular Degeneration (AMD) Sales Market Share (2011-2016)
Table Glaxosmithkline Plc Basic Information List
Table Glaxosmithkline Plc Age-Related Macular Degeneration (AMD) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Glaxosmithkline Plc Age-Related Macular Degeneration (AMD) Sales Market Share (2011-2016)
Table Neurotech Pharmaceuticals, Inc. Basic Information List
Table Neurotech Pharmaceuticals, Inc. Age-Related Macular Degeneration (AMD) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Neurotech Pharmaceuticals, Inc. Age-Related Macular Degeneration (AMD) Sales Market Share (2011-2016)
Table Novartis Ag Basic Information List
Table Novartis Ag Age-Related Macular Degeneration (AMD) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis Ag Age-Related Macular Degeneration (AMD) Sales Market Share (2011-2016)
Table Ophthotech Corporation Basic Information List
Table Ophthotech Corporation Age-Related Macular Degeneration (AMD) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Ophthotech Corporation Age-Related Macular Degeneration (AMD) Sales Market Share (2011-2016)
Table Regeneron Pharmaceutical, Inc. Basic Information List
Table Regeneron Pharmaceutical, Inc. Age-Related Macular Degeneration (AMD) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Regeneron Pharmaceutical, Inc. Age-Related Macular Degeneration (AMD) Sales Market Share (2011-2016)
Table Stemcells Inc. Basic Information List
Table Stemcells Inc. Age-Related Macular Degeneration (AMD) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Stemcells Inc. Age-Related Macular Degeneration (AMD) Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Age-Related Macular Degeneration (AMD)
Figure Manufacturing Process Analysis of Age-Related Macular Degeneration (AMD)
Figure Age-Related Macular Degeneration (AMD) Industrial Chain Analysis
Table Raw Materials Sources of Age-Related Macular Degeneration (AMD) Major Manufacturers in 2015
Table Major Buyers of Age-Related Macular Degeneration (AMD)
Table Distributors/Traders List
Figure United States Age-Related Macular Degeneration (AMD) Production and Growth Rate Forecast (2016-2021)
Figure United States Age-Related Macular Degeneration (AMD) Revenue and Growth Rate Forecast (2016-2021)
Table United States Age-Related Macular Degeneration (AMD) Production Forecast by Type (2016-2021)
Table United States Age-Related Macular Degeneration (AMD) Consumption Forecast by Application (2016-2021)

More Publications

Need Help?

Ask a Question

Market Reports

All Categories